IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 199 filers reported holding IMMUNOGEN INC in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $264,000 | +79.6% | 25,081 | +9.5% | 0.04% | +105.6% |
| Q4 2017 | $147,000 | -90.6% | 22,912 | -88.7% | 0.02% | -89.4% |
| Q3 2017 | $1,558,000 | +477.0% | 203,597 | +435.6% | 0.17% | +415.2% |
| Q2 2017 | $270,000 | +250.6% | 38,015 | +32.5% | 0.03% | +83.3% |
| Q3 2016 | $77,000 | -67.9% | 28,700 | -63.2% | 0.02% | -70.0% |
| Q2 2016 | $240,000 | – | 78,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |